The European Society of Cardiology (ESC) / European Society of Hypertension (ESH) 2018 guidelines on hypertension follow previous joint guidelines issued in 2003, 2007 and 20133. The 2018 guideline1 was refined, modified and expanded to incorporate new results published on the diagnosis and treatment of individuals with an elevated blood pressure1.
New definitions of hypertension are introduced. ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), Calcium channel blockers (CCBs) and (thiazide-) Diuretics are all suitable and recommended for the initiation and maintenance of antihypertensive treatment. Dual combination treatment (ACEi or ARB + CCB or diuretic) of these first-line agents are recommended for initial therapy.
The definition of hypertension have changed in Europe (ESC/ESH Guideline 20181) and also in the USA (ACC/AHA Guideline 20172). As both definitions differ, a comparison can be found in the following table:Download ESC/ESH Guidelines